Supernus Pharmaceuticals Inc (SUPN)
Total Non-Current Liabilities
$49.50M
Quarterly · Period ending: · USD
SUPN Total Non-Current Liabilities
Latest reported$49.50Mperiod ending
Latest reported$49.50Mperiod ending
SUPN Quarterly Total Non-Current Liabilities ($76.02M → $49.50M)
Quarterly total non-current liabilities
High-resolution chart · PNG
SUPN total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 49,504,999 | |
| 49,991,000 | |
| 52,763,000 | |
| 39,458,000 | |
| 32,145,000 | |
| 34,813,000 | |
| 39,943,000 | |
| 44,043,000 | |
| 49,719,000 | |
| 60,370,000 | |
| 65,961,000 | |
| 85,435,000 | |
| 120,601,000 | |
| 148,113,000 | |
| 128,346,000 | |
| 114,344,000 | |
| 118,003,000 | |
| 526,513,000 | |
| 557,922,000 | |
| 509,861,000 | |
| 504,034,000 | |
| 512,187,000 | |
| 514,136,000 | |
| 501,537,000 | |
| 555,770,000 | |
| 408,148,000 | |
| 404,267,000 | |
| 399,935,000 | |
| 396,800,000 | |
| 393,724,000 | |
| 363,435,000 | |
| 362,230,000 | |
| 358,373,000 | |
| 354,203,000 | |
| 33,984,000 | |
| 28,859,000 | |
| 31,449,000 | |
| 34,189,000 | |
| 37,071,000 | |
| 40,098,000 | |
| 12,039,000 | |
| 12,211,000 | |
| 13,758,000 | |
| 14,206,000 | |
| 15,389,000 | |
| 18,198,000 | |
| 38,661,000 | |
| 38,080,000 | |
| 41,634,000 | |
| 41,405,000 | |
| 51,131,000 | |
| 86,241,000 | |
| 80,057,000 | |
| 10,781,000 | |
| 13,436,000 | |
| 17,793,000 | |
| 20,104,000 | |
| 23,016,000 | |
| 25,517,000 | |
| 88,316,000 | |
| 76,122,000 | |
| 76,011,320 | |
| 76,022,000 |